๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Drug combination disappoints in pancreatic cancer

โœ Scribed by Jane Bradbury

Book ID
117783691
Publisher
The Lancet
Year
2005
Tongue
English
Weight
102 KB
Volume
6
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The pemetrexed/gemcitabine combination i
The pemetrexed/gemcitabine combination in pancreatic cancer
โœ Hedy Lee Kindler ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB

Gemcitabine has modest antitumor activity in advanced pancreatic cancer. New agents are clearly needed. Pemetrexed (ALIMTA) is a novel antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. Pemetrexed has shown in vitro activity agai

Targeted drug delivery in pancreatic can
Targeted drug delivery in pancreatic cancer
โœ Xianjun Yu; Yuqing Zhang; Changyi Chen; Qizhi Yao; Min Li ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 408 KB
Overcoming drug resistance in pancreatic
Overcoming drug resistance in pancreatic cancer
โœ Long, Jiang; Zhang, Yuqing; Yu, Xianjun; Yang, Jingxuan; LeBrun, Drake G; Chen, ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Informa plc ๐ŸŒ English โš– 357 KB